Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling-Yang Hao

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Journal of Medicinal Chemistry|September 9, 2021
Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating CancerThomas D Aicher, Chad A Van Huis, Alexander R Hurd, et al.
Nature|July 10, 2024
Interferon subverts an AHR-JUN axis to promote CXCL13<sup>+</sup> T cells in lupusCalvin Law, Vanessa Sue Wacleche, Ye Cao, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Journal of Medicinal Chemistry|September 9, 2021
Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating CancerThomas D Aicher, Chad A Van Huis, Alexander R Hurd, et al.
Nature|July 10, 2024
Interferon subverts an AHR-JUN axis to promote CXCL13<sup>+</sup> T cells in lupusCalvin Law, Vanessa Sue Wacleche, Ye Cao, et al.
Pageof 3